Literature DB >> 23412185

Patient estimates of healthcare costs in trauma and orthopaedics.

Francis Brooks1, Vishal Paringe, Aurey Tonge, James Lewis, Khitish Mohanty.   

Abstract

AIM: The cost of treating trauma and musculoskeletal conditions per head of population in Wales in 2007-2010 increased from £183 to £236, representing an increase in National Health Service total expenditure of 13.11 %. This study was set up to determine whether the public is aware of the general costs of treatment within the trauma and orthopaedic department.
METHOD: Patients completed a questionnaire asking them what they thought the cost was for common orthopaedic treatments, investigations and implants. This questionnaire was completed whilst they were waiting to be seen in clinic.
RESULTS: We had 183 completed questionnaires from patients with an average age of 43.47 years (range, 18-85 years). All patients were members of the public, with no previous experience of NHS work or costing. The inter-rater reliability was 0.39(95 % CI, 0.178-0.559). A product was accurately assessed if the estimates were between 50 and 200 % of the true cost. Costs of arm slings and crutches were well estimated by >80 % of the respondents. Approximately 60 % accurately estimated the cost of a fracture clinic visit, hospital transport and physiotherapy and lower limb plaster. Only 22.5 % accurately estimated the cost of a knee X-ray with 37.6 % overestimating the cost by more than tenfold. Other expenses that were underestimated by patients were the costs of a total hip replacement (in 58.3 %), fixation of an ankle fracture (in 32.2 %) and an overnight inpatient stay (in 10.9 %).
CONCLUSION: Whilst the costs of physical products were well estimated by our cohort of patients, the costs of less tangible products, such as radiology and operations, were poorly estimated. Our study shows that there is a poor public perception of the true cost for investigation and operative treatment of common trauma and orthopaedic conditions.

Entities:  

Mesh:

Year:  2012        PMID: 23412185     DOI: 10.1007/s00590-012-1052-6

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  7 in total

1.  Reality of the NHS budget squeeze.

Authors:  Richard Vize
Journal:  BMJ       Date:  2011-12-12

2.  Public reporting of cost and quality information in orthopaedics.

Authors:  Youssra Marjoua; Craig A Butler; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2012-04       Impact factor: 4.176

3.  Cost awareness among Swedish physicians working at the emergency department.

Authors:  Ulf Martin Schilling
Journal:  Eur J Emerg Med       Date:  2009-06       Impact factor: 2.799

4.  Long-term funding. From riches to rags--the NHS must plan for an era of austerity.

Authors:  Alastair McLellan
Journal:  Health Serv J       Date:  2011-06-02

5.  The cost of medicines in the United Kingdom. A survey of general practitioners' opinions and knowledge.

Authors:  J Silcock; M Ryan; C M Bond; R J Taylor
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

6.  Patients poorly estimate the overall costs of a total knee arthroplasty and strongly overestimate the surgeon's fee.

Authors:  José M H Smolders; Corné J M Van Loon; Willard J Rijnberg; Job L C Van Susante
Journal:  Acta Orthop Belg       Date:  2007-06       Impact factor: 0.500

7.  Prevalence and cost of musculoskeletal disorders: a population-based, public hospital system healthcare consumption approach.

Authors:  Richard H Osborne; Mandana Nikpour; Lucy Busija; Vijaya Sundararajan; Ian P Wicks
Journal:  J Rheumatol       Date:  2007-11-01       Impact factor: 4.666

  7 in total
  2 in total

Review 1.  The ABC and pain in trauma.

Authors:  Andreas F Mavrogenis; Vasilios G Igoumenou; Andreas Kostroglou; Kostis Kostopanagiotou; Theodosis Saranteas
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-01-23

2.  Penny-wise and pound-foolish.

Authors:  Asbjørn Årøen; Brian M Devitt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-02-09       Impact factor: 4.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.